Sign in
CompletedNo phase

Genicular Artery Embolization as Pain Treatment of Knee Osteoarthritis

Key facts

Who runs it
Copenhagen University Hospital, Rigshospitalet
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
17 people enrolled
Started
20 Sept 2022
Ended
19 Dec 2023
Type of study
Interventional
Treatments tested
  • Transarterial geniculate artery embolization
Record updated
20 December 2024

Who can take part

Age
30 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Body Mass Index < 35 kg / m2
  • X-ray verified mild to moderate KOA (Kellgren Lawrence grade 1-3 [24]), obtained maximum 6 months prior to inclusion
  • Moderate to severe knee pain during walking (Visual Analog Scale (VAS) > 50 mm) - resistant to minimum 3 months physiotherapy
  • Willing, able, and mentally competent to provide informed consent

Who cannot take part

  • Prior ipsilateral open knee surgery
  • Current/recent (within 4 weeks) use of oral corticosteroids
  • Estimated glomerular filtration rate < 60 ml / min / 1.73 m2 (All participants: blood sample maximum 30 days prior to GAE. Participants > 60 years: another blood sample maximum 3 months prior to last MRI scan with contrast agents)
  • Local infection in knee or groin areas
  • Generalized pain syndrome (e.g. fibromyalgia) or nerve root compression syndromes
  • Active malignancy
  • Known history of allergy to contrast media
  • Diabetes (I+II)
  • Liver disease
  • Only one kidney, former kidney surgery, reduced kidney function or failure (chronic or acute)
  • Diseases affecting the bone metabolism (E.g. severe osteoporosis, Paget's disease, or hyperparathyroidism)
  • INR > 1.4, Platelets ≤ 40 x 109 / l (All participants: blood sample maximum 30 days prior to GAE)
  • Moderate to severe pain in ipsilateral lower limb joints; VAS > 2
  • Intermittent claudication
  • Rheumatoid arthritis or seronegative arthropathies
  • Ipsilateral arthroscopy within 6 months
  • Ipsilateral intra-articular knee injection within 6 months
  • Pregnant or planned pregnancy during the study period
  • Lactation
  • Contra-indications for MRI (e.g. metallic foreign bodies, etc)
  • Manifest hyperthyroidism
  • Antithrombotic treatment except acetylsalicylic acid
  • American Society of Anesthesiologists classification > 3

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to investigate the safety and efficacy of geniculate artery embolization (GAE) as pain treatment in patients with mild to moderate knee osteoarthritis.

The group in the trial

  • Mild to moderate knee osteoarthritis (Kellgren Lawrence Score 1-3)Treatment being tested

    Geniculate artery embolization will be performed in all eligible participants.

    Treatment: Transarterial geniculate artery embolization

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Genicular Artery Embolization as Pain Treatment of Mild to Moderate Knee Osteoarthritis
Record updated
20 December 2024